Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07002437 · ClinicalTrials.gov registry record · NA

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

A NA study of Spinal Cord Injuries (SCI), sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT07002437: Recruiting NA study of Spinal Cord Injuries (SCI), sponsored by University of Florida.

NCT07002437 is a NA study of Spinal Cord Injuries (SCI) that is actively recruiting participants, run by University of Florida. The registered enrollment target is 18 participants, below the 66-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07002437, a NA study of Spinal Cord Injuries (SCI), is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Spinal cord injury (SCI) disrupts neural pathways to respiratory motor neurons, diminishing breathing capacity and airway defense (e.g., cough). Indeed, respiratory impairment is a leading cause of infection, re-hospitalization and death after SCI. There is a critical need for new strategies to restore breathing ability and airway defense in people with SCI. Acute intermittent hypoxia (AIH) - repetitive exposure to brief episodes of low inspired oxygen - is a promising strategy to restore breathing capacity by promoting spinal neuroplasticity. Exciting outcomes in \>12 SCI trials completed to date demonstrate that AIH improves human respiratory and limb function. Unfortunately, \~40% of individuals exhibit minimal response to AIH, making it essential to 1) optimize AIH protocols to maximize functional benefits; and 2) identify genetic biomarkers distinguishing those most/least likely to benefit from AIH-based treatments. The purpose of the pilot study, to be conducted in a small sample of participants with sub-acute SCI (2 weeks to 6 months post injury), is to preliminarily compare the effects of two intermittent hypoxia protocols. Since AIH-induced plasticity may be induced via serotonin or adenosine-driven mechanisms and these pathways compete and inhibit each other, each protocol favors a distinct mechanistic pathway. Our long-term objective is to test the hypothesis that a longer duration (i.e., augmented) hypoxia protocol, favoring adenosine mechanisms, enhances respiratory motor plasticity more than an AIH protocol targeting serotonin mechanisms (low O2 + CO2) in people with sub-acute SCI. Since an individual's genetics can influence the response to rehabilitation, we are also investigating how certain genes are related to breathing changes after these treatments. Data acquired through this pilot study will be used to inform a larger, more definitive clinical trial and will contribute to estimations of the magnitude and direction of effects.

Primary Outcome

Maximal inspiratory pressure is a non-invasive measure of the maximal force achieved when breathing in against an occluded airway.

Conditions Studied

Interventions

  • OTHER Augmented Acute Intermittent Hypoxia (aAIH)
  • OTHER Acute Intermittent Hypercapnic-Hypoxia (AIHH)
  • OTHER Sham AIH

Study Locations (1)

Florida

  • Brooks Rehabilitation - Jacksonville

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2025-11-20
Est. Completion 2027-07
Phase NA
University of Florida

1,106 total trials

What NCT07002437 shows while recruiting

NCT07002437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 66-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Spinal Cord Injuries (SCI) appearing as the primary indexed condition, and to 3 interventions - of which Augmented Acute Intermittent Hypoxia (aAIH) is the first listed.

NCT07002437 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07002437 about?

NCT07002437 is a clinical study titled "Hypoxia Pathways for Early Recovery After Spinal Cord Injury". Spinal cord injury (SCI) disrupts neural pathways to respiratory motor neurons, diminishing breathing capacity and airway defense (e.g., cough). Indeed, respiratory impairment is a leading cause of infection, re-hospitalization and death after SCI. There is a critical need for new strategies to rest...

What is the current status of trial NCT07002437?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-11-20. Estimated completion is 2027-07.

What conditions does trial NCT07002437 study?

This clinical trial studies the following conditions: Spinal Cord Injuries (SCI).

What interventions are being tested in trial NCT07002437?

The interventions under investigation include: Augmented Acute Intermittent Hypoxia (aAIH) (OTHER), Acute Intermittent Hypercapnic-Hypoxia (AIHH) (OTHER), Sham AIH (OTHER).

Who is sponsoring clinical trial NCT07002437?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07002437 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries (SCI)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07002437's enrollment target sits among peer trials

18 9th of 9 higher than 1 of 9 other Spinal Cord Injuries (SCI) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries (SCI) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07002437, the US trial registry maintained by the National Library of Medicine. NCT07002437 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.